$TPST (TEMPEST THERAPEUTICS) — 8-K: Tempest Therapeutics Appoints Nancy Freda-Smith to Board of Directors, Audit Committee Chair

Nancy Freda-Smith has been appointed to Tempest Therapeutics' board of directors and will serve as Chair of the Audit Committee. She brings more than 30 years of finance and audit experience, most recently as Chief Audit and Risk Officer at Ralph Lauren, where she oversaw operations spanning over 30 countries and more than $7 billion in revenue. She previously served as an Independent Director and Audit Committee Member of Chuy's Holdings and as Managing Director at Deloitte & Touche LLP. She is a Certified Public Accountant and Certified Fraud Examiner.

Nancy Freda-Smith has been appointed to Tempest Therapeutics' board of directors and will serve as Chair of the Audit Committee. She brings more than 30 years of finance and audit experience, most rec